¼¼°èÀÇ ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ½ÃÀå
Endoscopic Ultrasound Needles
»óǰÄÚµå : 1588884
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,260,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,780,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ¼¼°è ½ÃÀåÀº 2030³â±îÁö 2¾ï 2,120¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â¿¡ 1¾ï 8,260¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 2¾ï 2,120¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â µ¿¾È 2.8%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÈíÀÔħ(EUS-FNA)Àº CAGR 2.7%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 1¾ï 5,050¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »ý°Ëħ(EUS-FNB) ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 2.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 4,980¸¸ ´Þ·¯, Áß±¹Àº CAGR 5.4%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ½ÃÀåÀº 2023³â 4,980¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 4,450¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â ºÐ¼® ±â°£ µ¿¾È 5.4%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 0.8%¿Í 2.1%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 1.4%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´ÃÀÌ Áø´Ü ÀýÂ÷¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÃÊÀ½ÆÄ ³»½Ã°æ(EUS) ¹Ù´ÃÀº ƯÈ÷ ¼ÒÈ­±â ¹× Á¾¾çÇÐ ºÐ¾ß¿¡¼­ Áø´Ü ¹× Ä¡·á ½Ã¼ú¿¡ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¹Ù´ÃÀº ¼ÒÈ­°ü, ÃéÀå, °£°ú °°Àº ÁÖº¯ Àå±â¿¡¼­ Á¶Á÷ »ùÇÃÀ» äÃëÇÏ´Â µ¥ »ç¿ëµÇ¾î ÃéÀå¾Ï, ³¶Á¾ ¹× ±âŸ ¾Ç¼º Á¾¾ç°ú °°Àº Áúº´À» Á¤È®ÇÏ°Ô Áø´ÜÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ÒÈ­±â ÁúȯÀÇ Áõ°¡¿Í º¹ºÎ Àå±â¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¾ÏÀÇ À¯º´·ü Áõ°¡´Â Á¤¹ÐÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ¿© EUS ħ¼úÀ» Çö´ë ÀÇÇп¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¿µ»ó ¾È³»¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â EUS ħÀº ÃÖ¼ÒÇÑÀÇ Ä§½À¼ºÀ¸·Î Áø´Ü Á¤È®µµ¿Í ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ¿© ÀÇ·á ½Ã¼³¿¡¼­ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ¾î¶»°Ô EUS ¹Ù´ÃÀ» °­È­Çϴ°¡?

±â¼ú Çõ½ÅÀº EUS ¹Ù´ÃÀÇ µðÀÚÀΰú ±â´ÉÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. ÃֽŠEUS ¹Ù´ÃÀº À¯¿¬¼º°ú Á¤È®¼ºÀÌ ¶Ù¾î³ª¸ç, Àǻ簡 Á¢±ÙÇϱ⠾î·Á¿î ½Åü ºÎÀ§¿¡ Á¢±ÙÇÏ¿© ¾çÁúÀÇ Á¶Á÷ »ùÇÃÀ» äÃëÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¹Ù´ÃÀÇ µðÀÚÀεµ ÁøÈ­ÇÏ¿© Á¶ÀÛ¼ºÀ» Çâ»ó½ÃŰ´Â ¹Ì¼¼ÇÑ Á÷°æÀÇ ¹Ù´Ã, ¾ÈÀüÇϰí È¿°úÀûÀÎ »ùÇøµÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Ãø¸é Ææ½ºÇü µðÀÚÀÎÀÇ ¹Ù´Ã°ú °°Àº Ư¼ö ¹Ù´Ãµµ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. EUS¿Í ¹Ì¼¼Ä§ÈíÀÔ(FNA) ¶Ç´Â ¹Ì¼¼Ä§»ý°Ë(FNB)ÀÇ Á¶ÇÕÀ» Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ Çõ½ÅÀÇ ¹ßÀüÀº ³ôÀº Áø´Ü Á¤È®µµ¸¦ º¸ÀåÇϰí ÀÇ·áÁøÀÇ º¹ÀâÇÑ ½Ã¼ú ¼öÇà ´É·ÂÀ» Çâ»ó½Ãų ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÇ·áÁøÀÇ ´É·ÂÀ» Çâ»ó½Ãŵ´Ï´Ù.

±ÔÁ¦¿Í ÇコÄÉ¾î Æ®·»µå°¡ ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ÇコÄÉ¾î µ¿ÇâÀº ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡¸ç, FDA ¹× EMA¿Í °°Àº ±ÔÁ¦ ±â°üÀº ½ÃÁß¿¡¼­ ÆÇ¸ÅµÇ´Â EUS ¹Ù´ÃÀÌ ¾ö°ÝÇÑ ¾ÈÀü ¹× À¯È¿¼º ±âÁØÀ» ÃæÁ·Çϵµ·Ï º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀº Á¦Á¶¾÷üÀÇ ½Å·Úµµ¸¦ ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ½Å±â¼ú äÅÃÀ» ÃËÁøÇÕ´Ï´Ù. ¶ÇÇÑ, ¾Ï Á¶±â ¹ß°ß°ú ÃÖ¼Òħ½ÀÀû Áø´Ü ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÃÖ¼ÒÇÑÀÇ À§ÇèÀ¸·Î »ó¼¼ÇÑ ¿µ»ó Áø´Ü°ú Á¶Á÷ »ùÇøµÀ» ÇÒ ¼ö ÀÖ´Â EUS À¯µµÇÏ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ È¸º¹ ½Ã°£À» ´ÜÃàÇϰí Àüü ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Â ºñ¼ö¼úÀû °³ÀÔÀ¸·Î ÀüȯÇϸ鼭, ÀÇ·á ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ Áø´Ü ¹æ¹ýÀ» ¿ì¼±¼øÀ§¿¡ µÎ°í ºñ¿ëÀ» ÁöºÒÇϰí ÀÖ½À´Ï´Ù.

ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ½ÃÀåÀÇ ¼ºÀåÀº Á¤È®Çϰí ÃÖ¼Òħ½ÀÀûÀÎ Áø´Ü µµ±¸°¡ ÇÊ¿äÇÑ ¼ÒÈ­±â¾Ï ¹× ±âŸ º¹ºÎ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °°Àº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, EUS ¹Ù´ÃÀÇ ¼³°è ¹× ¿µ»ó ó¸® ´É·ÂÀÇ ±â¼úÀû ¹ßÀüÀº Á¤È®¼º°ú Áø´Ü °á°ú¸¦ °³¼±Çϱâ À§ÇØ EUS ¹Ù´ÃÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Ï Á¶±â ¹ß°ß°ú ¸ÂÃã ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ Ç¥Àû »ý°ËÀ» °¡´ÉÇÏ°Ô Çϴ ÷´Ü Áø´Ü ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϰí ÀÖ´Â °Íµµ ½ÃÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú EUS ½Ã¼ú¿¡ ´ëÇÑ È¯±ÞÀ» Æ÷ÇÔÇÑ À¯¸®ÇÑ ÀÇ·á Á¤Ã¥µµ ÀÌ·¯ÇÑ ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀ» Á¾ÇÕÇϸé ÃÊÀ½ÆÄ ³»½Ã°æ ¹Ù´Ã ½ÃÀåÀÇ ¼ºÀå°ú ÁøÈ­¸¦ º¸ÀåÇÏ°í °í±Þ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 42°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Endoscopic Ultrasound Needles Market to Reach US$221.2 Million by 2030

The global market for Endoscopic Ultrasound Needles estimated at US$182.6 Million in the year 2023, is expected to reach US$221.2 Million by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Aspiration Needles (EUS-FNA), one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$150.5 Million by the end of the analysis period. Growth in the Biopsy Needles (EUS-FNB) segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$49.8 Million While China is Forecast to Grow at 5.4% CAGR

The Endoscopic Ultrasound Needles market in the U.S. is estimated at US$49.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$44.5 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global Endoscopic Ultrasound Needles Market - Key Trends & Drivers Summarized

Why Are Endoscopic Ultrasound Needles Essential in Diagnostic Procedures?

Endoscopic ultrasound (EUS) needles are essential tools in diagnostic and therapeutic procedures, particularly in the fields of gastroenterology and oncology. These needles are used to obtain tissue samples from the gastrointestinal tract and surrounding organs, such as the pancreas and liver, allowing for accurate diagnosis of conditions like pancreatic cancer, cysts, and other malignancies. The rise in gastrointestinal diseases and the increasing prevalence of cancers that affect abdominal organs have fueled the demand for precise diagnostic tools, making EUS needles indispensable in modern medical practice. Their ability to provide real-time imaging guidance, along with minimal invasiveness, enhances diagnostic accuracy and patient outcomes, contributing to their widespread adoption in healthcare facilities.

How Are Technological Innovations Enhancing EUS Needles?

Technological advancements have significantly improved the design and functionality of EUS needles. Modern EUS needles are engineered for greater flexibility and precision, enabling doctors to access hard-to-reach areas within the body and obtain high-quality tissue samples. Needle designs have evolved to include fine-gauge options for better maneuverability, as well as specialized needles such as those with a side-fenestrated design that facilitate safe and effective sampling. Additionally, manufacturers are integrating advanced materials and coatings to reduce patient discomfort and improve tissue retrieval efficiency. The development of these innovations, including the combination of EUS with fine-needle aspiration (FNA) or fine-needle biopsy (FNB), ensures high diagnostic accuracy and enhances the capabilities of healthcare professionals in performing complex procedures.

Are Regulations and Healthcare Trends Shaping the Market?

Regulatory approvals and healthcare trends significantly influence the endoscopic ultrasound needles market. Regulatory bodies such as the FDA and EMA play a crucial role in ensuring that the EUS needles available in the market meet rigorous safety and efficacy standards. Successful regulatory clearances not only boost manufacturer credibility but also enhance the adoption of new technologies by healthcare providers. Furthermore, the increasing focus on early cancer detection and minimally invasive diagnostic techniques has led to a growing demand for EUS-guided procedures, as they offer detailed imaging and tissue sampling with minimal risk. Healthcare systems are increasingly prioritizing and reimbursing such diagnostic methods, reflecting the shift towards non-surgical interventions that can reduce patient recovery times and overall healthcare costs.

What Is Driving the Growth of the Endoscopic Ultrasound Needles Market?

The growth in the endoscopic ultrasound needles market is driven by several factors, including the increasing prevalence of gastrointestinal cancers and other abdominal diseases, which necessitate accurate and minimally invasive diagnostic tools. Technological advancements in needle design and imaging capabilities further boost the adoption of EUS needles, as they improve precision and diagnostic outcomes. Additionally, the growing emphasis on early cancer detection and personalized medicine supports the market, as healthcare providers invest in advanced diagnostic solutions that enable targeted biopsies. Regulatory approvals and favorable healthcare policies, including reimbursement for EUS procedures, also play a crucial role in expanding access to these technologies. Collectively, these factors ensure the growth and evolution of the endoscopic ultrasound needles market, meeting the rising demand for advanced diagnostic tools.

Select Competitors (Total 42 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â